Thomas Graham's Top Holdings: Analysis of Kahn Brothers Group's Portfolio Focus
Thomas Graham's portfolio, managed by Kahn Brothers Group, is heavily weighted in Financial Services and Healthcare, with significant allocations to Citigroup and Bayer AG.

Thomas Graham, managing investments through the Kahn Brothers Group, maintains a substantial portfolio valued at approximately $564 million as of March 31, 2026. This analysis focuses on the top holdings within Graham's portfolio, highlighting significant positions and recent changes.
Leading the portfolio is Citigroup Inc (C), an American global financial services corporation. Graham holds over 840,000 shares, representing about 16.91% of the total portfolio. The stock's value in Graham's account is approximately $95.4 million. There was a slight decrease in shares held compared to the previous period, with a -4.04% change in allocation.
Bayer AG Spons ADR (BAYRY) is the next largest holding, accounting for 13.26% of the portfolio. Graham holds nearly 6.5 million shares, valued at around $74.8 million. This position saw a reduction in shares, with a -3.56% change from the prior period.
Flagstar Financial, Inc. (NYCB) holds the third position with a 9.53% allocation. Graham owns over 4 million shares, valued at approximately $53.8 million. The position experienced a modest decline, with a -2.24% change in shares.
The fourth largest holding is Walt Disney (DIS), representing 6.47% of the portfolio. Graham holds around 379,000 shares, valued at about $36.5 million. The position saw a decrease, with shares down by -3.92%.
Alphabet Inc Class C (GOOG) follows with a 6.21% allocation. Graham holds approximately 122,000 shares, valued at around $35.0 million. This position also saw a significant reduction, with shares decreasing by -9.89%.
Seaboard Corp (SEB) and Organon & Co (OGN) both hold a portfolio allocation of 5.88%. Graham's stake in Seaboard Corp is valued at approximately $33.2 million, while the investment in Organon & Co is worth about $33.2 million. Notably, Graham significantly increased his position in Organon & Co, adding 52.56% more shares during the period.
BP PLC (BP) is another significant holding at 5.18% allocation. Graham owns around 622,000 shares, valued at approximately $29.2 million. This position saw a substantial reduction, with shares down by -40.08%.
Completing the top ten holdings is Merck & Co. Inc. (MRK) at 4.85% allocation. Graham holds about 227,000 shares, valued at approximately $27.3 million. The position experienced a significant decline, with shares down by -47.15%.
Finally, Zillow Group (Z) holds a 4.0% allocation. Graham owns 545,000 shares, valued at about $22.6 million. This position saw a doubling of shares during the period.
For a detailed view of Thomas Graham's investment profile, including all holdings and performance, visit the investor profile on Insiderset: Thomas Graham - Kahn Brothers Group. For more information on any specific stock holding, such as Citigroup (C) or Bayer AG (BAYRY), explore the stock profiles: Citigroup Inc (C) and Bayer AG Spons ADR (BAYRY).